Pathogens face varying microenvironments in vivo, but suitable experimental systems and analysis tools to dissect how three-dimensional (3D) tissue environments impact pathogen spread are lacking. Here we develop an Integrative method to Study Pathogen spread by Experiment and Computation within Tissue-like 3D cultures (INSPECT-3D), combining quantification of pathogen replication with imaging to study single-cell and cell population dynamics. We apply INSPECT-3D to analyze HIV-1 spread between primary human CD4 T-lymphocytes using collagen as tissue-like 3D-scaffold. Measurements of virus replication, infectivity, diffusion, cellular motility and interactions are combined by mathematical analyses into an integrated spatial infection model to estimate parameters governing HIV-1 spread. This reveals that environmental restrictions limit infection by cell-free virions but promote cell-associated HIV-1 transmission. Experimental validation identifies cell motility and density as essential determinants of efficacy and mode of HIV-1 spread in 3D. INSPECT-3D represents an adaptable method for quantitative time-resolved analyses of 3D pathogen spread.
Computer-aided digital chest radiograph interpretation (CAD) can facilitate high-throughput screening for tuberculosis (TB), but its use in population-based active case-finding programs has been limited. In an HIV-endemic area in rural South Africa, we used a CAD algorithm (CAD4TBv5) to interpret digital chest x-rays (CXR) as part of a mobile health screening effort. Participants with TB symptoms or CAD4TBv5 score above the triaging threshold were referred for microbiological sputum assessment. During an initial pilot phase, a low CAD4TBv5 triaging threshold of 25 was selected to maximize TB case finding. We report the performance of CAD4TBv5 in screening 9,914 participants, 99 (1.0%) of whom were found to have microbiologically proven TB. CAD4TBv5 was able to identify TB cases at the same sensitivity but lower specificity as a blinded radiologist, whereas the next generation of the algorithm (CAD4TBv6) achieved comparable sensitivity and specificity to the radiologist. The CXRs of people with microbiologically confirmed TB spanned a range of lung field abnormality, including 19 (19.2%) cases deemed normal by the radiologist. HIV serostatus did not impact CAD4TB’s performance. Notably, 78.8% of the TB cases identified during this population-based survey were asymptomatic and therefore triaged for sputum collection on the basis of CAD4TBv5 score alone. While CAD4TBv6 has the potential to replace radiologists for triaging CXRs in TB prevalence surveys, population-specific piloting is necessary to set the appropriate triaging thresholds. Further work on image analysis strategies is needed to identify radiologically subtle active TB.
Developers proposing new machine learning for health (ML4H) tools often pledge to match or even surpass the performance of existing tools, yet the reality is usually more complicated. Reliable deployment of ML4H to the real world is challenging as examples from diabetic retinopathy or Covid-19 screening show. We envision an integrated framework of algorithm auditing and quality control that provides a path towards the effective and reliable application of ML systems in healthcare. In this editorial, we give a summary of ongoing work towards that vision and announce a call for participation to the special issue Machine Learning for Health: Algorithm Auditing & Quality Control in this journal to advance the practice of ML4H auditing.
Background Computer-aided digital chest radiograph (CXR) interpretation can facilitate high-throughput screening for tuberculosis (TB), but its use in population-based screening has been limited. We applied an automated image interpretation algorithm, CAD4TBv5, prospectively in an HIV-endemic area. Methods Participants underwent CXR and, for those with symptoms or lung field abnormality, microbiological assessment of sputum collected at a mobile camp in rural South Africa. CAD4TBv5 scored each CXR on a 0-100 scale in the field. An expert radiologist, blinded to the CAD4TBv5 score and other data, assessed CXRs for 1) lung field abnormality and 2) findings diagnostic of active TB (R+). We estimated the performance of CAD4TBv5 for triaging (identifying lung field abnormality as a criteria for sputum examination) and diagnosis (detection of active TB as defined by microbiologic (M+) or radiologic (R+) gold standards). Findings For triaging, a CAD4TBv5 threshold of 25 identified abnormal lung fields with a sensitivity of 90.3% and specificity of 48.2%. For diagnosis, CAD4TBv5 had less agreement with the microbiological reference standard (M+) used to define definite TB (AUC 0.78) than with the radiological reference standard (R+) used to define probable TB (AUC 0.96). HIV-serostatus did not impact CAD4TB's performance. Interpretation A low CAD4TBv5 threshold was required to achieve acceptable triaging sensitivity. Low specificity at this threshold led to high rates of sputum collection despite normal lung fields. CAD4TBv5 had difficulty identifying microbiologically-confirmed TB cases with subtle radiological features but had excellent agreement with the radiologist in identifying radiologically-defined TB cases. We conclude that computer-aided CXR interpretation can be useful in population-based screening in HIV-endemic settings, but threshold selection should be guided by setting-specific piloting and priorities. CXR interpretation algorithms require refinement for the identification of radiologically-subtle early TB.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.